What did @matteochemical actually say?
The caption is doing most of the heavy lifting here, because the transcript itself is incoherent and appears to be a transcription artifact or machine error. The actual spoken content cannot be verified from the transcript provided. So this fact-check focuses on the written claims: that BPC-157 and TB-500 "don't require injury" to justify use, and that they can be used "in prevention" ahead of demanding training blocks, powerlifting meets, bodybuilding shows, or rugby seasons.
That is a meaningful clinical claim. It is not just saying these peptides help you heal faster after you get hurt. It is saying healthy, uninjured athletes should use them proactively to reduce injury risk before it happens. That is a different bar, and it deserves a harder look.
Does the science back this up?
Partly, but the evidence base is much weaker than this kind of confident social media framing suggests. Most of what we know about BPC-157 comes from animal studies, and almost none of it involves prophylactic use in healthy subjects.
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. Rodent studies, including work by Sikiric et al. published repeatedly in Current Pharmaceutical Design (2018) and Journal of Physiology-Paris (2000, 2006), show accelerated tendon, ligament, and muscle healing after induced injury. The mechanism appears to involve upregulation of growth hormone receptor expression and nitric oxide pathways. Impressive in rats. There are no completed randomized controlled trials in humans.
TB-500 is a synthetic version of Thymosin Beta-4, a peptide involved in actin regulation and cell migration. Animal studies show it promotes wound healing and reduces inflammation (Goldstein et al., Annals of the New York Academy of Sciences, 2012). Again, no published human RCTs exist for athletic or prophylactic use.
Using either peptide "in prevention" in healthy humans is speculative. The leap from "accelerates healing in injured rodents" to "prevents injury in healthy athletes" is not a small one.
What did they get wrong, and what did they get right?
What they got right: there is a plausible biological rationale for why peptides with pro-healing properties might support tissue resilience during high training loads. Connective tissue is constantly being stressed and micro-damaged during heavy training. If BPC-157 genuinely accelerates repair of micro-tears, using it during periods of high training volume is not an unreasonable hypothesis. That is a fair framing of where the science is pointing.
What they got wrong, or at least oversimplified:
- Presenting prophylactic use as established practice rather than an untested extrapolation from injury-recovery data.
- The caption implies efficacy in healthy humans is known. It is not. We do not have human trials on this, period.
- No mention that both peptides are not approved by any regulatory agency for human use. In most countries, including Italy, using or recommending unapproved peptides for performance purposes sits in a legally and medically gray zone.
- No mention of purity, sourcing, or the real risk that research-grade peptides sold online vary wildly in quality and contamination risk (Brennan et al., Drug Testing and Analysis, 2021).
What should you actually know?
If you are a competitive athlete considering BPC-157 or TB-500 before a demanding season, here is the honest picture. The theoretical rationale is not crazy. The animal data is genuinely interesting. But you would be self-experimenting with unregulated compounds based on rodent studies, with no established dosing protocol validated in humans, no long-term safety data, and real risk of contaminated product if you source from unregulated suppliers.
These are not approved drugs. They are not supplements. They are not the same as prescribed peptide therapies dispensed through a licensed compounding pharmacy under clinical supervision. That distinction matters legally and medically.
For anyone pursuing peptide therapy through a regulated telehealth platform, the conversation about whether prophylactic use makes sense for your training block is exactly the kind of thing that should happen with a licensed provider who knows your health history, not from a caption on Instagram. The science is evolving, and that is precisely why clinical oversight exists.